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P R E V I E W S
When considering the p53 gene family,
one is struck by their conspicuous simi-
larities as well as their intriguing differ-
ences. Structurally, the p53 family
members’ kinship is obvious, as they
share a common domain topology and
bear significant sequence homology
within their transactivation, DNA binding,
and tetramerization domains (reviewed in
Melino et al., 2002). At this point, howev-
er, far more is understood about p53 and
its function as a pivotal node in the DNA
damage checkpoint. Upon genotoxic
insult, p53 becomes modified, stabilized,
and thereby activated to regulate tran-
scription of its downstream target genes
important in many cellular functions,
including cell cycle arrest and apoptosis.
While p53’s central role in apoptosis and
tumor suppression is proven, the extent
to which the other members of the p53
family can support or recapitulate its
functions is unclear. Nevertheless, p73
can activate at least a subset of p53 tar-
get genes independently of p53 and also
can mediate p53-independent apoptosis
in response to a number of chemothera-
peutic agents (Irwin et al., 2003).
Interestingly, however, p63 and p73 are
required for p53-dependent apoptosis as
well as activation of some proapoptotic
p53 target genes in mouse embryo
fibroblasts expressing E1a in response to
cytotoxic agents (Flores et al., 2002).
Understanding the mechanisms by which
the p53 family members individually and
together regulate transcription continues
to be an important challenge for revealing
their respective roles in tumor
suppression.
A recent elegant paper from
Montovani et al. links p73 with the Pin1
peptidyl-prolyl-isomerase in apoptosis,
and as such may begin to provide a
mechanism for coregulation of the p53
family (Montovani et al., 2004). Pin1 medi-
ates cis/trans isomerization of proteins at
serine-proline or threonine-proline (SP or
TP) motifs. The ensuing conformational
change produces a variety of functional
outcomes in many proteins central to
tumorigenesis, including cyclin D1, β
catenin, NF-κB, and even p53 itself.
Substrate recognition by Pin1 requires
phosphorylation of SP or TP motifs by
multiple families of proline-directed kinas-
es, including cyclin-dependent kinases
(CDKs) and mitogen-activated protein
kinases (MAPKs) (reviewed in Lu, 2003).
Montovani et al. demonstrate that
Pin1 strongly enhances p73-dependent
apoptosis in p53 null cell lines, an obser-
vation that correlates with the ability of
Pin1 to augment p73’s ability to induce
proapoptotic target genes, including
Bax, Pig3, and p53AIP1. The Pin1-p73
interaction is phosphorylation-depen-
dent and seems to be mediated by three
key phosphorylation sites within the
poly-proline region of p73 that exist only
in the α and β isoforms of this protein.
Mutation of these 3 residues abrogates
Pin1 binding as well as transcriptional
regulatory activity of p73. Furthermore,
the authors show by a partial proteolysis
assay that Pin1 can directly induce con-
formational change(s) in p73 in vitro,
indicating that the Pin1-p73 interaction is
direct and that p73 is a bona fide sub-
strate for Pin1 isomerization. Binding of
Pin1 often enhances substrate half-life,
and indeed, siRNA-mediated knockdown
of Pin1 destabilizes p73 protein both in
the presence and absence of DNA
damage.
The signaling pathway converging
on p73, activated by two chemothera-
peutic agents cisplatinum (CDDP) and
adriamycin (ADR), relies principally on
the c-Abl tyrosine kinase (White and
Prives, 1999). Direct phosphorylation of
p73 by c-Abl on Y99, among other sites,
can stabilize and activate p73 protein.
Connecting this pathway with Pin1 is
the finding that c-Abl activates proline-
directed p38 MAPK to phosphorylate
TP sites within p73 (Sanchez-Prieto et
al., 2002).Thus, the c-Abl pathway likely
creates Pin1 recognition motifs on p73
through MAPK. Indeed, Montovani et al.
show that CDDP and ADR as well as
overexpression of c-Abl or p38-MAPK
stimulate Pin1-p73 association. This is
dependent on c-Abl, as p73 mutated at
Y99 is not active in these assays, and
siRNA depletion of c-Abl inhibits the
p73-Pin1 association. Conversely, c-Abl
cannot stabilize or activate p73 in the
context of Pin1 knockdown by siRNA.
Taken together, these observations
strongly implicate a strict functional
interdependence between c-Abl and
Pin1 in activating p73 after genotoxicity.
In addition to tyrosine phosphoryla-
tion, c-Abl is also required for p300-
dependent acetylation of p73, and this
modification enhances activation of pro-
apoptotic p73 target promoters (Costanzo
et al., 2002). Indeed, Montovani et al.
found that DNA damage-dependent p73
acetylation is defective in Pin1 null cells,
and coexpression of Pin1 enhances both
the p300-p73 interaction as well as the
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ensuing acetylation of p73. In a well con-
strued experiment, they further demon-
strated that purified Pin1 enhances the
interaction of in vitro-translated p73 with
purified p300. Thus, their data imply that
the Pin1-induced p73 conformational
change directly promotes association
between p73 and a vital transcriptional
coactivator, p300.
Supporting the in vivo relevance of
their observations, Montovani et al. show
that siRNA-mediated knockdown of Pin1
or p73 reduces CDDP induced apoptosis
in a p53 null cell line and also reduces
induction of an important p53-dependent
proapoptotic target gene, PUMA. Finally,
using a chromatin immunoprecipitation
(ChIP) assay, the authors show that Pin1
siRNA treatment leads to a marked
decrease in the association of endoge-
nous p73 with the p53AIP1 promoter
after treatment with CDDP. Whether this
reflects a direct effect of Pin1 on the
intrinsic ability of p73 to bind to DNA or is
the indirect result of increased p73 pro-
tein levels was not determined.Whatever
the mechanism, these data suggest that
the intermolecular associations and
posttranscriptional modifications promot-
ed by Pin1 are required for stable associ-
ation of p73 with at least some of its
target promoters (Figure 1A).
p73 is not the only member of the
p53 family regulated by Pin1. Indeed, it
was previously demonstrated by this
group and others that p53 itself is regu-
lated by Pin1 in a manner very similar to
that shown for p73 (Pulverer, 2002). Pin1
inducibly binds p53 after DNA damage
and alters both its stability and transcrip-
tional activity. Interestingly, ADR-induced
association of p53 with two of its target
promoters, p21 and Mdm2, is compro-
mised in Pin1 null mouse embryo fibrob-
lasts (Zheng et al., 2002), a similar
observation to that described for p73.
The fact that Pin1 can regulate both p53
and p73 may help to explain why, in
some settings, the absence of p63 and
p73 precludes stable association of p53
with a subset of its target promoters, and
conversely that the absence of p53 simi-
larly affects promoter binding by p63
(Flores et al., 2002). An admittedly spec-
ulative model to reconcile these mecha-
nistically mystifying observations would
posit that Pin1 (alone or in concert with
other factors) acts as a molecular key-
stone of p53 family transcriptional activa-
tion (Figure 1B). Pin1 may function to
stabilize and assemble a transcriptional
complex involving p53, p63, p73, and
perhaps other coactivators like p300
(Figure 1B).
Future experimentation will hopefully
explore this exciting prospect and many
questions can be approached. First, is
the third p53 family member, p63, also a
substrate for Pin1? Intriguingly, p63 has
several conserved phosphorylation sites
that, like p73, may be Pin1 substrates.
Second, does Pin1 itself participate in
complexes containing p53 family mem-
bers that are associated with chromatin?
It should be possible using a ChIP assay
to determine Pin1’s presence at p53 tar-
get promoters. Third, does the absence
of Pin1 affect recruitment of additional
factors to p53 responsive promoters? A
recent study demonstrated that the pre-
viously shown transcriptional coregula-
tors of p53, ASPP1 and ASPP2,
potentiate the function of endogenous
p63 and p73 (Bergamaschi et al., 2004).
Perhaps they too are present in a com-
plex involving p53 family members and
Pin1. Further supporting the possibility
that Pin1 may play a specific role in tran-
scriptional regulation is the observation
that Pin1 can directly regulate the func-
tion of RNA polymerase II (Xu et al.,
2003).
In sum, the data presented in
Montovani et al. not only delineates a
new regulatory interaction between p73
and Pin1, but also describes how this
integrates into the known p73 signaling
pathway, and ultimately how Pin1 affects
p73’s proapoptotic function in vivo. As
with all good studies, in hinting that Pin1
may be the glue holding the p53 family
together, it sets the field off in new direc-
tions.
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Figure 1. Pin1 and the p53 family
A: Model proposed by Montovani et al.
(2004) in which c-Abl and Pin1 promote
p73s stable interaction with the p53AIP1
promoter. 
B: Speculative model of p53 family coregula-
tion by Pin1, whereby Pin1 facilitates assem-
bly of transcriptional complexes containing
p53, p63, and p73, as well as other cofactors.
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